Taking into consideration the extensive evidence for a role of RNASEL in prostate cancer, we performed a meta-analysis of all eligible case-control studies in order to derive a more precise estimation of the association of the Arg462Gln and Asp541Glu polymorphisms in RNASEL and prostate cancer risk. The gene discussed is RNASEL; the disease is prostate carcinoma.